| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $56,534,686 ) (Continued on the next page) |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 001 | 2 | NIH | 3/9/2026 | $22,954 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 001 | 4 | NIH | 1/14/2026 | $202,498 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 3 | NIH | 1/2/2026 | $39,094 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 001 | 5 | NIH | 2/25/2026 | $60,098 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 4 | NIH | 3/9/2026 | $528,581 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 000 | 7 | NIH | 2/27/2026 | $332,169 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01NS126489 | Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations | 000 | 4 | NIH | 2/23/2026 | $220,967 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG081362 | Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease | 000 | 2 | NIH | 3/9/2026 | $771,678 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133304 | A novel pathway controls liver injury in NASH | 000 | 5 | NIH | 2/27/2026 | $521,908 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | $578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | -$578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 002 | 20 | NIH | 2/24/2026 | $98,810 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | $102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | -$102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 000 | 3 | NIH | 2/25/2026 | $387,500 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | -$267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 003 | 20 | NIH | 2/24/2026 | $68,871 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | AY2AX000159 | Rapamycin + Semaglutide To Optimize, Restore, and Extend Healthspan (RSTORE-H) | 000 | 1 | NIH | 2/24/2026 | $11,904,972 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI196999 | Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity | 000 | 1 | NIH | 2/5/2026 | $421,223 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | $154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 010 | 2 | NIH | 3/2/2026 | -$154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HL175081 | Characterize TMEM94 as ER Mg2+ uptake machinery and pathophysiological consequences. | 000 | 2 | NIH | 5/12/2026 | $529,902 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 002 | 4 | NIH | 3/30/2026 | $256,972 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM137798 | Deciphering the chromatin-based DNA damage response pathway | 001 | 7 | NIH | 4/9/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01CA283749 | The role of tumor-macrophage hybrid cells in prostate cancer metastasis | 001 | 3 | NIH | 4/29/2026 | $8,575 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086271 | The role of paracrine growth factor signaling in thymus function and age-associated dysfunction | 000 | 3 | NIH | 4/9/2026 | $494,677 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AA031407 | Deciphering RNA Splicing Control of Lipid Metabolism and Alcoholic Liver Injury | 000 | 3 | NIH | 5/7/2026 | $505,745 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM163544 | Spatiotemporal regulation of DNA metabolism pathways | 000 | 1 | NIH | 5/7/2026 | $433,125 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG086496 | The Hippo signaling pathway as a target of intervention for Alzheimer’s disease | 000 | 3 | NIH | 4/7/2026 | $539,512 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30CA301788 | Regulatory Mechanisms of APOBEC3B Mutagenic Activity in Cancer | 000 | 1 | NIH | 4/6/2026 | $40,367 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA281726 | Novel mechanism of chemokine nitration in bladder cancer | 000 | 3 | NIH | 4/24/2026 | $389,933 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK107680 | Ketones, Muscle Metabolism, and SGLT2 Inhibitors | 001 | 10 | NIH | 4/1/2026 | $647,334 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AI174181 | Development and function of skin-resident innate-like T cells at early postnatal stages | 001 | 3 | NIH | 4/24/2026 | $54,277 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F32DA063281 | Cannabidiol and buprenorphine: A poly-pharmacy approach to treat opioid use disorder | 000 | 2 | NIH | 4/1/2026 | $26,593 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R25NS115552 | Summer Physiology Undergraduate Researcher (SPUR) Program | 000 | 6 | NIH | 4/1/2026 | $135,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31DK143733 | Circadian Regulation of Liver-derived Endostatin | 000 | 1 | NIH | 3/20/2026 | $39,298 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 001 | 3 | NIH | 4/13/2026 | $576 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31AI197805 | Structure and Function of E3 Ligases | 000 | 1 | NIH | 4/13/2026 | $39,874 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA279696 | The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer | 000 | 4 | NIH | 4/10/2026 | $374,561 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS131652 | CB1 receptors mediate metaplasticity in the cerebellar circuit | 001 | 3 | NIH | 3/25/2026 | $39,043 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F31DK143733 | Circadian Regulation of Liver-derived Endostatin | 001 | 1 | NIH | 3/20/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG087361 | Investigating the Impact of Novel Senescent Microglia in Alzheimer's Disease Progression | 003 | 2 | NIH | 4/10/2026 | $0 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 13 | NIH | 3/24/2026 | $684,914 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 002 | 2 | NIH | 3/25/2026 | $274,600 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01NS128574 | Chronic Intermittent Hypoxia and Hyperalgesic Priming | 000 | 4 | NIH | 3/23/2026 | $622,505 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK129676 | Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers | 000 | 5 | NIH | 3/23/2026 | $682,149 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA299621 | Development of first-in-class AAK1 PROTACs for ovarian cancer | 000 | 1 | NIH | 3/25/2026 | $593,338 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01MH099660 | Postnatal mechanisms of cognitive development in mice | 000 | 14 | NIH | 4/10/2026 | $551,281 |
|
